However, in our previous study [17,18] we employed different cancer cell lines including BxPC3luc, PANC-1luc and MCF-7/DOXluc as cell models and confirmed that gemcitabine and doxorubicin could upregulate the ABCG2 mediated drug efflux function in different cell lines. The gene discussed is ABCG2; the disease is cancer.